Sanofi Loses Suit Against FDA Over Generic Eloxatin

Law360, New York (July 26, 2010, 7:51 PM EDT) -- A federal judge on Monday threw out a lawsuit brought by Sanofi-Aventis U.S. LLC and Debiopharm SA that sought to force the U.S. Food and Drug Administration to rescind its approvals of applications to make generic versions of the lucrative colon cancer drug Eloxatin.

Also on Monday, Sanofi-Aventis filed a separate suit in the U.S. District Court for the District of Columbia arguing that the FDA should withdraw its approval of Sandoz Pharmaceutical Industries Inc.'s bid for a regulatory green light to make a generic version...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.